FDA Approves Medical-Grade Maggots For Debridement Therapy

FDA Approves Medical-Grade Maggots For Debridement Therapy The biomedical developer Cuprina Holdings thinks this is the first debridement product to use this particular species, dubbed Medifly Maggots. Maggot debridement therapy has been associated with a lower risk of lower-limb amputation in diabetics with non-healing lesions, MedPage Today reports. https://kffhealthnews.org/morning-breakout/science-and-innovations-061626/